Literature DB >> 25342093

Serum leptin levels do not correlate with disease activity in rheumatoid arthritis.

Sibel Yilmaz Oner1, Omur Volkan2, Can Oner3, Alperen Mengi2, Haner Direskeneli1, Demet Ataman Tasan4.   

Abstract

OBJECTIVES: Leptin, is a fat tissue hormone which effects energy expenditure, food intake , hematopoiesis, osteogenesis, angiogenesis, reproductive and immune systems. We aimed to determine serum leptin levels and investigate the association between disease activity and other parameters in RA patients.
METHODS: Patients with RA (n=106) as the study group, healthy controls (n=52) and osteoarthritis (OA) patients (n=37) as a control group were enrolled to the study. RA patients were categorized in four different groups according to DAS28 scores: remission ,low (LDA), moderate (MDA) or high (HDA) disease activity .
RESULTS: No differences were present between the body mass indices of the three groups. Mean leptin levels in RA patients, OA group and healthy individuals were 25,60 ± 13,41, 23,03 ± 11,51 and 23,81 ± 12,85 ng/ml, respectively and no significant difference was present between the groups. Nine of (8,5%) RA patients were in remission, 16 (15,1%) were in LDA, 40 (37,7%) in MDA and 41 (38,7%) were in HDA. Leptin levels did not correlate with DAS28 scores of RA patients (r=-0,12, p=0,11). Mean leptin levels in RA patients with remission was 32,65 ± 7, 28 in LDA 23,94 ± 10,94 in MDA 26,73 ± 14,92 and in HDA 23,59 ± 13,50 ng/ml (p=NS). No associations were observed between leptin levels and CRP, ESR, RF positivity and disease duration.
CONCLUSIONS: Our study revealed no correlation of disease activity and serum leptin levels. Therefore leptin does not seem to be an appropriate biomarker to monitorize inflammation in RA.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25342093

Source DB:  PubMed          Journal:  Acta Reumatol Port        ISSN: 0303-464X            Impact factor:   1.290


  12 in total

1.  Leptin as an obesity marker in rheumatoid arthritis.

Authors:  Maria Fernanda Brandão de Resende Guimarães; Marcus Vinícius Melo de Andrade; Carla Jorge Machado; Érica Leandro Marciano Vieira; Maria Raquel da Costa Pinto; Antônio Lúcio Teixeira Júnior; Adriana Maria Kakehasi
Journal:  Rheumatol Int       Date:  2018-06-11       Impact factor: 2.631

2.  Association between leptin and IL-6 concentrations with cardiovascular risk in patients with rheumatoid arthritis.

Authors:  José Antonio De Jesús Batún-Garrido; Marisol Salas-Magaña; Isela Esther Juárez-Rojop
Journal:  Clin Rheumatol       Date:  2017-11-03       Impact factor: 2.980

Review 3.  Obesity, Fat Mass and Immune System: Role for Leptin.

Authors:  Vera Francisco; Jesús Pino; Victor Campos-Cabaleiro; Clara Ruiz-Fernández; Antonio Mera; Miguel A Gonzalez-Gay; Rodolfo Gómez; Oreste Gualillo
Journal:  Front Physiol       Date:  2018-06-01       Impact factor: 4.566

4.  Leptin is associated with disease activity but not with anthropometric indices in rheumatoid arthritis patients.

Authors:  Amela Dervišević; Halima Resić; Šekib Sokolović; Nermina Babić; Nesina Avdagić; Asija Začiragić; Amela Bečiragić; Almir Fajkić; Orhan Lepara; Almira Hadžović-Dzuvo
Journal:  Arch Med Sci       Date:  2017-01-13       Impact factor: 3.318

Review 5.  Metabolic Checkpoints in Rheumatoid Arthritis.

Authors:  Valentina Pucino; Michelangelo Certo; Gilda Varricchi; Giancarlo Marone; Francesco Ursini; Francesca Wanda Rossi; Amato De Paulis; Claudio Mauro; Karim Raza; Christopher Dominic Buckley
Journal:  Front Physiol       Date:  2020-04-17       Impact factor: 4.566

6.  Diagnostic issues in difficult-to-treat rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of difficult-to-treat rheumatoid arthritis.

Authors:  Nadia M T Roodenrijs; Melinda Kedves; Attila Hamar; György Nagy; Jacob M van Laar; Désirée van der Heijde; Paco M J Welsing
Journal:  RMD Open       Date:  2021-01

7.  Adipocytokines in Untreated Newly Diagnosed Rheumatoid Arthritis: Association with Circulating Chemokines and Markers of Inflammation.

Authors:  Georgios K Vasileiadis; Anna-Carin Lundell; Yuan Zhang; Kerstin Andersson; Inger Gjertsson; Anna Rudin; Cristina Maglio
Journal:  Biomolecules       Date:  2021-02-21

Review 8.  Leptin in Osteoarthritis and Rheumatoid Arthritis: Player or Bystander?

Authors:  Djedjiga Ait Eldjoudi; Alfonso Cordero Barreal; María Gonzalez-Rodríguez; Clara Ruiz-Fernández; Yousof Farrag; Mariam Farrag; Francisca Lago; Maurizio Capuozzo; Miguel Angel Gonzalez-Gay; Antonio Mera Varela; Jesús Pino; Oreste Gualillo
Journal:  Int J Mol Sci       Date:  2022-03-05       Impact factor: 5.923

9.  Assessment of Adipokines, CXCL16 Chemokine Levels in Patients With Rheumatoid Arthritis Combined With Metabolic Syndrome.

Authors:  Lyudmila Gennadyevna Turgunova; Anna Andreevna Shalygina; Janis Pavlovich Zalkalns; Dmitriy Anatolyevich Klyuyev; Lyudmila Leonidovna Akhmaltdinova; Raushan Sultanovna Dosmagambetova
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2021-02-05

10.  Relationship Between Leptin and Neopterin Levels and Disease Activation Parameters in Patients With Rheumatoid Arthritis.

Authors:  Arif Gülkesen; Gürkan Akgöl; Türkan Tuncer; Gül Ayden Kal; Selda Telo; Ahmet Kürşad Poyraz; Arzu Kaya
Journal:  Arch Rheumatol       Date:  2016-04-14       Impact factor: 1.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.